These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 35632692)

  • 1. Role of Microbiota in Viral Infections and Pathological Progression.
    Mizutani T; Ishizaka A; Koga M; Tsutsumi T; Yotsuyanagi H
    Viruses; 2022 May; 14(5):. PubMed ID: 35632692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral Infections, the Microbiome, and Probiotics.
    Harper A; Vijayakumar V; Ouwehand AC; Ter Haar J; Obis D; Espadaler J; Binda S; Desiraju S; Day R
    Front Cell Infect Microbiol; 2020; 10():596166. PubMed ID: 33643929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Commensal Microbiota and Viral Infection: A Comprehensive Review.
    Li N; Ma WT; Pang M; Fan QL; Hua JL
    Front Immunol; 2019; 10():1551. PubMed ID: 31333675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virome and bacteriome: two sides of the same coin.
    Stern J; Miller G; Li X; Saxena D
    Curr Opin Virol; 2019 Aug; 37():37-43. PubMed ID: 31177014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiome (Bacteria, Fungi, and Viruses) and HIV Infection: Revealing Novel Treatment Strategies.
    Ma J; Wen S; Dong A; Fan W; Kang Y
    Mol Nutr Food Res; 2023 Dec; 67(23):e2300566. PubMed ID: 37867202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysbiosis of human microbiome and infectious diseases.
    Gupta A; Singh V; Mani I
    Prog Mol Biol Transl Sci; 2022; 192(1):33-51. PubMed ID: 36280324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus and oral microbiota: mutual influence on the establishment of a viral gingival reservoir in individuals under antiretroviral therapy.
    Ramos Peña DE; Pillet S; Grupioni Lourenço A; Pozzetto B; Bourlet T; Motta ACF
    Front Cell Infect Microbiol; 2024; 14():1364002. PubMed ID: 38660490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of the gut microbiota in severe SARS-CoV-2 infection.
    Liu Y; Kuang D; Li D; Yang J; Yan J; Xia Y; Zhang F; Cao H
    Cytokine Growth Factor Rev; 2022 Feb; 63():98-107. PubMed ID: 35131164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Findings on Gut Microbiota Mediated Immune Modulation against Viral Diseases in Chicken.
    Abaidullah M; Peng S; Kamran M; Song X; Yin Z
    Viruses; 2019 Jul; 11(8):. PubMed ID: 31349568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Viruses in the Pathogenesis of Immune-Mediated Gastro-Intestinal Diseases.
    Bernardi F; Ungaro F; D'Amico F; Zilli A; Parigi TL; Massimino L; Allocca M; Danese S; Furfaro F
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the Microbiota on Viral Infections.
    Campbell DE; Li Y; Ingle H; Baldridge MT
    Annu Rev Virol; 2023 Sep; 10(1):371-395. PubMed ID: 37071931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota Status in COVID-19: An Unrecognized Player?
    Donati Zeppa S; Agostini D; Piccoli G; Stocchi V; Sestili P
    Front Cell Infect Microbiol; 2020; 10():576551. PubMed ID: 33324572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific changes of enteric mycobiota and virome in inflammatory bowel disease.
    Chu Y; Jiang MZ; Xu B; Wang WJ; Chen D; Li XW; Zhang YJ; Liang J
    J Dig Dis; 2018 Jan; 19(1):2-7. PubMed ID: 29266753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
    Xiang H; Liu QP
    World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review.
    Liu TFD; Philippou E; Kolokotroni O; Siakallis G; Rahima K; Constantinou C
    Infection; 2022 Aug; 50(4):815-847. PubMed ID: 34671922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The triad: respiratory microbiome - virus - immune response in the pathophysiology of pulmonary viral infections.
    Porto BN; Moraes TJ
    Expert Rev Respir Med; 2021 May; 15(5):635-648. PubMed ID: 33605840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it time for microbiome-based therapies in viral infections?
    Sadiq FA
    Virus Res; 2021 Jan; 291():198203. PubMed ID: 33132161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-talk between immune system and microbiota in COVID-19.
    Baradaran Ghavami S; Pourhamzeh M; Farmani M; Raftar SKA; Shahrokh S; Shpichka A; Asadzadeh Aghdaei H; Hakemi-Vala M; Hossein-Khannazer N; Timashev P; Vosough M
    Expert Rev Gastroenterol Hepatol; 2021 Nov; 15(11):1281-1294. PubMed ID: 34654347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota-derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID-19: An open-label pilot study.
    Zhang L; Xu Z; Mak JWY; Chow KM; Lui G; Li TCM; Wong CK; Chan PKS; Ching JYL; Fujiwara Y; Chan FKL; Ng SC
    J Gastroenterol Hepatol; 2022 May; 37(5):823-831. PubMed ID: 35170078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.